Hasil Filter

1977

Total database: 17430
Struktur (SMILES)
1074 (54.3%)
Target
1046 (52.9%)
Genomik
39 (2.0%)
Referensi
1977 (100.0%)

Tipe Molekul

Distribusi Wujud Zat

Status Regulasi

Hasil Pencarian (1977)

Halaman 31 / 40
Reslizumab Approved DB06602
biotech | CAS: 241473-69-8

Reslizumab is a humanized interleukin-5 (IL-5) antagonist monoclonal antibody (IgG4 kappa) that is produced by recombinant DNA technology in murine myeloma non-secreting 0 (NS0) cells. IL-5 is a pro-inflammatory cytokine that is responsible for the growth and…

Kategori:
Amino Acids, Peptides, and ProteinsAnti-Asthmatic AgentsAntibodies +12
Target Protein:
Interleukin-5
Waktu ParuhThe half-life is ap…
Vol. DistribusiThe approximate vol…
KlirensReslizumab clearanc…
Genetik -
biotech

Arexvy (respiratory syncytial virus vaccine, adjuvanted) is an adjuvanted vaccine developed by GlaxoSmithKline Biologicals. It comprises lyophilized recombinant respiratory syncytial virus glycoprotein F (RSVPreF3) stabilized in pre-fusion conformation as the…

Kategori:
Respiratory syncytial virus (RSV) vaccinesVaccinesViral Vaccines
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Revumenib Approved DB18515
small molecule | CAS: 2169919-21-3

Abnormal gene rearrangements at chromosome locus 11q23, called KMT2A rearrangements or translocations, are present in 5%-10% of patients with acute leukemias and are the sole genetic aberration found in the majority of infant acute lymphoblastic leukemia case…

Kategori:
Acids, CarbocyclicAmidesBenzene Derivatives +17
Target Protein:
Menin
Waktu ParuhFollowing oral admi…
Vol. DistribusiThe the geometric m…
KlirensFollowing oral admi…
Genetik -
Rexin G DB16450
biotech | CAS: 1023923-93-4

Rexin-G is a tumor-targeted, injectable retroviral vector carrying a mutant form of the cyclin G1 gene. It is under development by Epeius Biotechnologies for the potential treatment of metastatic cancer. It is also being investigated for preventing SARSCOV-2 …

Kategori:
Experimental Unapproved Treatments for COVID-19
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Rezafungin Approved DB16310
small molecule | CAS: 1396640-59-7

Rezafungin is an echinocandin antifungal drug.[A258393,L45633] Unlike other echinocandins such as [caspofungin] and [micafungin], rezafungin has long?acting pharmacokinetics and a high stability that allows for it to have long dosing intervals maintaining hig…

Kategori:
Amino Acids, Peptides, and ProteinsAnti-Infective AgentsAntifungal Agents +8
Target Protein:
1,3-beta-glucan synthase component FKS11,3-beta-glucan synthase component GSC2
Waktu ParuhRezafungin has a te…
Vol. DistribusiRezafungin has a vo…
KlirensRezafungin has an e…
Genetik -
Ribavirin Approved DB00811
small molecule | CAS: 36791-04-5

Producing a broad-spectrum activity against several RNA and DNA viruses, Ribavirin is a synthetic guanosine nucleoside and antiviral agent that interferes with the synthesis of viral mRNA. It is primarily indicated for use in treating hepatitis C and viral he…

Kategori:
Anti-Infective AgentsAntiinfectives for Systemic UseAntimetabolites +13
Target Protein:
Inosine-5'-monophosphate dehydrogenase 1RNA-directed RNA polymerase LGenome polyprotein +2
Gen Terkait:
IFNL3
Waktu ParuhThe terminal half-l…
Vol. DistribusiRibavirin displays …
KlirensThe total apparent …
Genetik 1 Varian
Rice bran oil Approved DB11293
biotech

Rice bran oil is extracted from the hard outer brown layer of rice after chaff (rice husk) used for high-temperature cooking methods such as deep frying and stir frying. It contains monosaturated fatty acids, polyunsaturated fatty acids, and saturated fatty a…

Kategori:
Biological ProductsComplex MixturesDietary Fats +7
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Ridogrel DB01207
small molecule | CAS: 110140-89-1

Ridogrel is a dual action drug useful for the prevention of systemic thrombo-embolism and as an adjunctive agent to thrombolytic therapy in acute myocardial infarction. However, there currently are no clinical indications for preferential use of ridogrel over…

Kategori:
Acids, AcyclicAntiplatelet agentsEnzyme Inhibitors +7
Target Protein:
Thromboxane-A synthaseThromboxane A2 receptor
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Rilematovir DB15672
small molecule | CAS: 1383450-81-4

Rilematovir is under investigation in clinical trial NCT04056611 (Effects of JNJ-53718678 in Adult and Adolescent Participants Who Had a Hematopoietic Stem Cell Transplantation and Who Are Infected With Respiratory Syncytial Virus (RSV)).

Kategori:
Heterocyclic Compounds, Fused-RingImidazoles
Target Protein:
Fusion glycoprotein F0
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Rilpivirine Approved DB08864
small molecule | CAS: 500287-72-9

Rilpivirine is non-nucleoside reverse transcriptase inhibitor (NNRTI) which is used for the treatment of HIV-1 infections in treatment-naive patients.[A31328] It is a diarylpyrimidine derivative.[A31329] The internal conformational flexibility of rilpivirine …

Kategori:
Anti-HIV AgentsAnti-Infective AgentsAnti-Retroviral Agents +43
Target Protein:
Reverse transcriptase/RNaseHSodium channel protein type 10 subunit alphaGag-Pol polyprotein +1
Waktu ParuhRilpivirine has a t…
Vol. DistribusiIn HIV-1 patients, …
KlirensIn HIV-1 patients, …
Genetik -
Rilvegostomig DB18991
biotech | CAS: 2640305-01-5

Rilvegostomig is under investigation in clinical trial NCT06109779 (Rilvegostomig + Chemotherapy as Adjuvant Therapy for Biliary Tract Cancer After Resection (Artemide-biliary01)).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Rimonabant Approved DB06155
small molecule | CAS: 168273-06-1

Rimonabant is an anorectic anti-obesity drug produced and marketed by Sanofi-Aventis. It is an inverse agonist for the cannabinoid receptor CB1. Its main avenue of effect is reduction in appetite. Rimonabant is the first selective CB1 receptor blocker to be a…

Kategori:
Agents producing tachycardiaAlimentary Tract and MetabolismAnti-Obesity Agents +12
Target Protein:
Cannabinoid receptor 1G-protein coupled receptor 55
Waktu Paruh6 to 9 days with no…
Vol. Distribusi-
Klirens-
Genetik -
Rindopepimut DB05374
small molecule | CAS: 1108208-65-6

Rindopepimut (CDX-110) is an injectable peptide cancer vaccine which targets a mutant protein called EGFRvIII present in about 25% to 30% of glioblastoma cases. The vaccine consists of the EGFRv3-specific peptide (a 13-amino acid mutant vIII epitope) conjugat…

Kategori:
Antineoplastic AgentsAntineoplastic Agents, ImmunologicalBiological Products +2
Target Protein:
Epidermal growth factor receptor
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Ripasudil DB13165
small molecule | CAS: 223645-67-8

Ripasudil, as hydrochloride hydrate (K-115), is a specifc Rho-associated coiled-coil containing protein kinase (ROCK) inhibitor used for the treatment of glaucoma and ocular hypertension. It was first approved for treatment in Japan in September 2014. This me…

Kategori:
AmidesAntiglaucoma Preparations and MioticsHeterocyclic Compounds, Fused-Ring +5
Target Protein:
Rho-associated protein kinase 1Rho-associated protein kinase 2
Waktu ParuhThe half life of Ri…
Vol. Distribusi-
KlirensRipasudil has a ren…
Genetik -
Risankizumab Approved DB14762
biotech | CAS: 1612838-76-2

Risankizumab is a fully humanized IgG1 monoclonal antibody (mAb) directed against interleukin 23 (IL-23).[L39885] It gained its first global approval in Japan in March 2019, followed by approval in Canada, the US, and Europe in April 2019.[A254716] Risankizum…

Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesAntibodies, Monoclonal +15
Target Protein:
Interleukin-23
Waktu ParuhThe terminal elimin…
Vol. DistribusiThe estimated stead…
KlirensThe estimated syste…
Genetik -
Ritlecitinib Approved DB14924
small molecule | CAS: 1792180-81-4

Ritlecitinib (PF-06651600) is a highly selective inhibitor of Janus kinase 3 (JAK3) and the tyrosine kinase expressed in hepatocellular carcinoma (TEC) kinase family. In June 2023, it was approved by the FDA for the treatment of severe alopecia areata in adul…

Kategori:
Antineoplastic and Immunomodulating AgentsCytochrome P-450 CYP1A2 InhibitorsCytochrome P-450 CYP1A2 Inhibitors (strength unknown) +16
Target Protein:
Tyrosine-protein kinase JAK3Tyrosine-protein kinase TecTyrosine-protein kinase ITK/TSK +3
Waktu ParuhRitlecitinib has a …
Vol. DistribusiRitlecitinib is pre…
KlirensRitlecitinib is pre…
Genetik -
Ritonavir Approved DB00503
small molecule | CAS: 155213-67-5

Ritonavir is an HIV protease inhibitor that interferes with the reproductive cycle of HIV. Although it was initially developed as an independent antiviral agent, it has been shown to possess advantageous properties in combination regimens with low-dose ritona…

Kategori:
Acids, AcyclicAgents Causing Muscle ToxicityAnti-HIV Agents +69
Target Protein:
Gag-Pol polyproteinPol polyproteinNuclear receptor subfamily 1 group I member 2
Waktu ParuhThe approximate hal…
Vol. DistribusiThe estimated volum…
KlirensThe apparent oral c…
Genetik -
Rivanicline DB05855
small molecule | CAS: 15585-43-0

Rivanicline (TC-2403, RJR-2403, (E)-metanicotine) is a partial agonist at neuronal nicotinic acetylcholine receptors, binding primarily to the ?4?2 subtype. It was originally developed as a potential treatment for Alzheimer's disease for its nootropic effects…

Kategori:
AlkaloidsPyridinesSolanaceous Alkaloids
Target Protein:
Neuronal acetylcholine receptor subunit beta-2Interleukin-8
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Rivaroxaban Approved DB06228
small molecule | CAS: 366789-02-8

Rivaroxaban is an anticoagulant and the first orally active direct factor Xa inhibitor. Unlike warfarin, routine lab monitoring of INR is not necessary. However there is no antidote available in the event of a major bleed. Only the 10 mg tablet can be taken w…

Kategori:
AnticoagulantsAntithrombinsBCRP/ABCG2 Substrates +17
Target Protein:
Coagulation factor X
Waktu ParuhThe terminal half l…
Vol. DistribusiThe steady state Vd…
KlirensSystemic clearance …
Genetik -
Rocaglamide DB15495
small molecule | CAS: 84573-16-0

Rocaglamide, also referred to as rocaglamide-A, is the eponymous member of a class of anti-cancer phytochemicals known as rocaglamides.[A186760] Rocaglamides are secondary metabolites of the plant genus _Aglaia_, and extracts of the plant have traditionally b…

Kategori:
Heterocyclic Compounds, Fused-Ring
Target Protein:
Prohibitin 1Transcription factor RelBNuclear factor NF-kappa-B p100 subunit +4
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Rocatinlimab DB18809
biotech | CAS: 2431972-52-8

Rocatinlimab is a subcutaneously administered anti-OX40 antibody developed for the treatment of moderate-to-severe atopic dermatitis. In clinical trials, it has shown significant efficacy and safety compared to a placebo. The drug works by targeting the OX40 …

Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesAntibodies, Monoclonal +7
Target Protein:
Tumor necrosis factor receptor superfamily member 4
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Roflumilast Approved DB01656
small molecule | CAS: 162401-32-3

Roflumilast is a highly selective phosphodiesterase-4 (PDE4) inhibitor.[A251385] PDE4 is a major cyclic-3',5?-adenosinemonophosphate (cyclic AMP, cAMP)-metabolizing enzyme [L37564] expressed on nearly all immune and pro-inflammatory cells, in addition to stru…

Kategori:
Acids, CarbocyclicAgents to Treat Airway DiseaseAmides +17
Target Protein:
cAMP-specific 3',5'-cyclic phosphodiesterase 4 (PDE4)
Waktu ParuhFollowing oral admi…
Vol. DistribusiFollowing a single …
KlirensPlasma clearance of…
Genetik -
Ronopterin DB12575
small molecule | CAS: 185243-78-1

Ronopterin has been used in trials studying the treatment of Traumatic Brain Injury.

Kategori:
CoenzymesEnzymes and CoenzymesHeterocyclic Compounds, Fused-Ring +3
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Ropeginterferon alfa-2b Approved DB15119
biotech | CAS: 1335098-50-4

Polycythemia vera (PV) is the most common Philadelphia chromosome-negative myeloproliferative neoplasm (MPN), characterized by increased hematocrit and platelet/leukocyte counts, an increased risk for hemorrhage and thromboembolic events, and a long-term prop…

Kategori:
Adjuvants, ImmunologicAlfa InterferonsAntineoplastic and Immunomodulating Agents +12
Target Protein:
Interferon alpha/beta receptor (IFNAR)
Waktu ParuhRopeginterferon alf…
Vol. DistribusiRopeginterferon alf…
KlirensRopeginterferon alf…
Genetik -
Rose bengal Approved DB11182
small molecule

Rose bengal is a pink stain derived as an analogue of fluorescein. Its disodium salt in ophthalmic solutions has been used as a diagnostic agent in suspected damage to conjunctival and corneal cells. It is also used in laboratory settings, including the prepa…

Kategori:
Coloring AgentsColouring AgentsCompounds used in a research, industrial, or household setting +12
Waktu ParuhDoses between 0.01 …
Vol. DistribusiNo information avai…
KlirensNo information avai…
Genetik -
Rosiglitazone Approved DB00412
small molecule | CAS: 122320-73-4

Rosiglitazone is an anti-diabetic drug in the thiazolidinedione class of drugs. It is marketed by the pharmaceutical company GlaxoSmithKline as a stand-alone drug (Avandia) and in combination with metformin (Avandamet) or with glimepiride (Avandaryl). Like ot…

Kategori:
Alimentary Tract and MetabolismBlood Glucose Lowering AgentsBSEP/ABCB11 Substrates +33
Target Protein:
Peroxisome proliferator-activated receptor gammaLong-chain-fatty-acid--CoA ligase 4Peroxisome proliferator-activated receptor alpha +4
Waktu Paruh3-4 hours (single o…
Vol. Distribusi* 17.6 L [oral volu…
Klirens* Oral clearance (C…
Genetik -
Rosnilimab DB18851
biotech | CAS: 2412764-40-8

Rosnilimab is under investigation in clinical trial NCT06041269 (A Study of Efficacy and Safety of Rosnilimab in Subjects With Moderate to Severe Rheumatoid Arthritis (RENOIR)).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Rosuvastatin Approved DB01098
small molecule | CAS: 287714-41-4

Rosuvastatin, also known as the brand name product Crestor, is a lipid-lowering drug that belongs to the statin class of medications, which are used to lower the risk of cardiovascular disease and manage elevated lipid levels by inhibiting the endogenous prod…

Kategori:
Agents Causing Muscle ToxicityAlimentary Tract and MetabolismAmides +32
Target Protein:
3-hydroxy-3-methylglutaryl-coenzyme A reductaseIntegrin alpha-L
Gen Terkait:
KIF6 HMGCR ABCG2
Waktu ParuhThe elimination hal…
Vol. DistribusiRosuvastatin underg…
Klirens-
Genetik 3 Varian
Rotenone DB11457
small molecule | CAS: 83-79-4

Rotenone is an isoflavone compound that naturally occurs in the jicama vine plant as well as many Fabaceae plants. It has broad spectrum insecticide and pesticide activity and is also toxic to fish.

Kategori:
AgrochemicalsBenzopyransChromones +10
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Rovazolac DB16320
small molecule | CAS: 1454288-88-0

Rovazolac is under investigation in clinical trial NCT03175354 (A Study in Subjects With Moderate Atopic Dermatitis).

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Royal jelly DB14250
biotech | CAS: 8031-67-2

Royal jelly is an animal extract used in some OTC (over-the-counter) products. It is not an approved drug.

Kategori:
BeesLipids
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Rozanolixizumab Approved DB14919
biotech | CAS: 1584645-37-3

Rozanolixizumab is a humanized high-affinity anti-human neonatal Fc receptor (FcRn) monoclonal antibody (IgG4P) targeting the immunoglobulin G (IgG). Rozonolixizumab itself is an IgG4P, an inactive isotype, to reduce the likelihood of unwanted chain exchange.…

Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesAntibodies, Monoclonal +10
Target Protein:
IgG receptor FcRn large subunit p51
Waktu Paruh-
Vol. DistribusiThe apparent volume…
KlirensThe apparent cleara…
Genetik -
Rozibafusp Alfa DB19233
biotech | CAS: 2143449-47-0

Rozibafusp Alfa is under investigation in clinical trial NCT04058028 (Efficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE)).

Kategori:
Amino Acids, Peptides, and ProteinsProteinsRecombinant Proteins
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
rsPSMA Vaccine Approved DB06361
biotech

Prostate-specific membrane antigen (PSMA) is an ?100 kDa transmembrane glycoprotein that is abundantly and preferentially expressed in prostate cancer, including recurrent and hormone-refractory cases. rsPSMA Vaccine is a subunit vaccine based on a novel rsPS…

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
RSV-604 DB15197
small molecule | CAS: 676128-63-5

RSV-604 is under investigation in clinical trial NCT00416442 (Safety, Tolerability and Pharmacokinetic Study of Single and Multiple Intravenous Doses of RSV604 in Healthy Subjects.).

Kategori:
AmidesBenzazepinesBenzene Derivatives +1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Rubidium Rb-82 Approved DB09479
small molecule

Rubidium chloride Rb-82 injection is a sterile nonpyrogenic solutions of rubidium Rb 82 chloride. It is indicated for Positron Emission Tomography (PET) imaging of the myocardium under rest or pharmacologic stress conditions to evaluate regional myocardial p…

Kategori:
Radioactive Diagnostic AgentRadiopharmaceutical Activity
Waktu Paruh1.27 minutes
Vol. Distribusi-
Klirens-
Genetik -
Rurioctocog alfa pegol Approved DB16007
biotech | CAS: 1417412-83-9

Rurioctocog alfa pegol is a pegylated recombinant human coagulation factor VIII or antihemophilic factor. Factor VIII is an essential protein involved in normal blood clotting; thus, a deficient level of functional factor VIII is associated with an elevated r…

Kategori:
Amino Acids, Peptides, and ProteinsBiological FactorsBlood Coagulation Factors +9
Target Protein:
von Willebrand factorCoagulation factor VIII
Waktu ParuhFollowing intraveno…
Vol. DistribusiFollowing intraveno…
KlirensFollowing intraveno…
Genetik -
RUS 3108 DB05911
small molecule

RUS 3108 is being developed for the treatment of atherosclerosis, the major cause of cardiovascular disorders such as heart attacks and stroke by Dr. Reddy’s Laboratories. The drug’s Phase I clinical trials have been initiated in Europe to assess safety of …

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
RUTI® Vaccine DB15853
biotech

The RUTI® Vaccine contains fragmented, purified and liposomed heat-inactivated Mycobacterium tuberculosis bacilli. The vaccine has demonstrated a reasonable safety profile and potent stimulation of the immune response against tuberculosis. Much like the BCG v…

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Ruxolitinib Approved DB08877
small molecule | CAS: 941678-49-5

Ruxolitinib, formerly known as INCB018424 or INC424, is an anticancer drug and a Janus kinase (JAK) inhibitor. It is a potent and selective inhibitor of JAK1 and JAK2,[A229698] which are tyrosine kinases involved in cytokine signalling and hematopoiesis.[A745…

Kategori:
Agents for Dermatitis, Excluding CorticosteroidsAntineoplastic AgentsAntineoplastic and Immunomodulating Agents +18
Target Protein:
Urokinase plasminogen activator surface receptorTyrosine-protein kinase JAK2Tyrosine-protein kinase JAK1 +2
Waktu ParuhThe mean eliminatio…
Vol. DistribusiThe mean volume of …
KlirensRuxolitinib clearan…
Genetik -
Ruzinurad DB19209
small molecule | CAS: 1638327-48-6

Ruzinurad is under investigation in clinical trial NCT04956432 (A Multicentre, Randomized, Double-blind, Allopurinol Controlled Study to Evaluate the Efficacy and Safety of SHR4640 in Subjects With Gout).

Kategori:
CycloparaffinsHeterocyclic Compounds, Fused-Ring
Target Protein:
Solute carrier family 22 member 12
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
RWJ-51084 DB03251
small molecule

Deskripsi belum tersedia.

Kategori:
Amino AcidsAmino Acids, BasicAmino Acids, Diamino +4
Target Protein:
Serine protease 1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
RWJ-56423 DB02812
small molecule

Deskripsi belum tersedia.

Target Protein:
Serine protease 1
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
RWJ-800088 DB18693
biotech | CAS: 257287-15-3

RWJ-800088 is a synthetic PEGylated thrombopoietin (TPO) mimetic (TPOm) peptide with no sequence homology to endogenous TPO.

Kategori:
Amino Acids, Peptides, and ProteinsBiological FactorsPeptides +2
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
S-40503 DB13938
small molecule | CAS: 404920-28-1

S-40503 is an investigational selective androgen receptor modulator (SARM) developed for the treatment of osteoporosis by the Japanese company Kaken Pharmaceuticals.

Kategori:
Heterocyclic Compounds, Fused-Ring
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
small molecule

S-hydroxycysteine is a solid. This compound belongs to the alpha amino acids and derivatives. These are amino acids in which the amino group is attached to the carbon atom immediately adjacent to the carboxylate group (alpha carbon), or a derivative thereof. …

Target Protein:
Tyrosine-protein phosphatase non-receptor type 1M-phase inducer phosphatase 2Proto-oncogene tyrosine-protein kinase Src +8
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Sabatolimab DB16322
biotech | CAS: 2252262-24-9

Sabatolimab is under investigation in clinical trial NCT03946670 (A Study of MBG453 in Combination With Hypomethylating Agents in Subjects With IPSS-R Intermediate, High or Very High Risk Myelodysplastic Syndrome (MDS).).

Kategori:
Amino Acids, Peptides, and ProteinsAntibodiesAntineoplastic Agents +8
Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Sacituzumab govitecan Approved DB12893
biotech | CAS: 1491917-83-9

Metastatic triple-negative breast cancer (mTNBC) is an aggressive form of breast cancer with limited treatment options involving cytotoxic chemotherapy agents.[A193653] Targeted chemotherapy through the application of antibody-conjugated agents (ADCs) is a re…

Kategori:
AlkaloidsAmino Acids, Peptides, and ProteinsAntibodies +20
Target Protein:
Tumor-associated calcium signal transducer 2DNA topoisomerase 1Far upstream element-binding protein 1
Waktu ParuhSacituzumab govitec…
Vol. DistribusiSacituzumab govitec…
KlirensSacituzumab govitec…
Genetik -
biotech | CAS: 2768350-77-0

Sacituzumab tirumotecan is a recombinant humanized IgG1 anti-TROP2 monoclonal antibody conjugated to a topoisomerase I inhibitor.

Waktu Paruh-
Vol. Distribusi-
Klirens-
Genetik -
Sacubitril Approved DB09292
small molecule | CAS: 149709-62-6

Sacubitril is a prodrug neprilysin inhibitor used in combination with valsartan to reduce the risk of cardiovascular events in patients with chronic heart failure (NYHA Class II-IV) and reduced ejection fraction. It was approved by the FDA after being given t…

Kategori:
Acids, AcyclicAgents causing angioedemaAmino Acids +13
Target Protein:
Neprilysin
Waktu ParuhThe half life of sa…
Vol. Distribusi103 L
Klirens-
Genetik -
Menampilkan 1501–1550 dari 1977
Sebelumnya Halaman 31 / 40 Berikutnya